February 2018 FDA Recall Drug by Fagron, Inc (D-0547-2018 - Microbial contamination of Non-Sterile Product; product contamination with yeast and mold (Paecilomyces saturatus and Aspergillus fumigatus).)

This Class II drug recall was voluntarily initiated by Fagron, Inc on February 14, 2018 for the product Drug. The FDA reported the reason for recall as microbial contamination of non-sterile product; product contamination with yeast and mold (paecilomyces saturatus and aspergillus fumigatus).. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0547-2018

Reason for Recall
Microbial contamination of Non-Sterile Product; product contamination with yeast and mold (Paecilomyces saturatus and Aspergillus fumigatus).
Initiated
02-14-2018
Reported
03-07-2018
Quantity
a) 1007 bottles (500 mL) and b) 738 bottles (4 L)

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
SyrSpend SF Suspending Base, a) 500 mL (NDC 51552-1079-5) and b) 4 L (NDC 51552-1079-9), Rx Only, Manufactured by Fagron Inc. St. Paul, MN 55120

Batch or Lot Expiration Information

Lot# a) 17I28-U80-039976, exp. 10/02/2020; b) 17I28-U80-039977, exp. 10/02/2020